Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - Surgery, 2021 - Elsevier
Background Patients with pancreatic neuroendocrine tumors often present with metastases,
which reduce survival. Molecular features associated with pancreatic neuroendocrine tumor …
被引用次数：8 相关文章

Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

C Tran, A Scott, G Li, S Sherman, PH Ear, J Howe - nanets.net
BACKGROUND: Patients with pancreatic neuroendocrine tumors (PNETs) often present with
metastases, which reduce survival. Molecular features associated with PNET tumorigenesis …

Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

C Tran, A Scott, G Li, S Sherman, PH Ear, J Howe - nanets.org
BACKGROUND: Patients with pancreatic neuroendocrine tumors (PNETs) often present with
metastases, which reduce survival. Molecular features associated with PNET tumorigenesis …

Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - Surgery, 2021 - iro.uiowa.edu
Background: Patients with pancreatic neuroendocrine tumors often present with metastases,
which reduce survival. Molecular features associated with pancreatic neuroendocrine tumor …

Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - Surgery, 2021 - surgjournal.com
Background Patients with pancreatic neuroendocrine tumors often present with metastases,
which reduce survival. Molecular features associated with pancreatic neuroendocrine tumor …

Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with pancreatic neuroendocrine tumors often present with metastases,
which reduce survival. Molecular features associated with pancreatic neuroendocrine tumor …

Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling.

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - Surgery, 2020 - europepmc.org
Background Patients with pancreatic neuroendocrine tumors often present with metastases,
which reduce survival. Molecular features associated with pancreatic neuroendocrine tumor …
[HTML] nih.gov

[HTML][HTML] Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

CG Tran, AT Scott, G Li, SK Sherman, PH Ear… - Surgery, 2021 - ncbi.nlm.nih.gov
Background Patients with pancreatic neuroendocrine tumors (PNETs) often present with
metastases, which reduce survival. Molecular features associated with PNET tumorigenesis …